Logo image of TRS

TRIMAS CORP (TRS) Stock Fundamental Analysis

NASDAQ:TRS - Nasdaq - US8962152091 - Common Stock - Currency: USD

30.11  +0.04 (+0.13%)

After market: 30.11 0 (0%)

Fundamental Rating

4

TRS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 22 industry peers in the Containers & Packaging industry. While TRS seems to be doing ok healthwise, there are quite some concerns on its profitability. TRS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year TRS was profitable.
TRS had a positive operating cash flow in the past year.
TRS had positive earnings in 4 of the past 5 years.
Each year in the past 5 years TRS had a positive operating cash flow.
TRS Yearly Net Income VS EBIT VS OCF VS FCFTRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.26%, TRS is in line with its industry, outperforming 50.00% of the companies in the same industry.
TRS has a Return On Equity of 4.59%. This is comparable to the rest of the industry: TRS outperforms 40.91% of its industry peers.
With a Return On Invested Capital value of 3.60%, TRS is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
TRS had an Average Return On Invested Capital over the past 3 years of 4.55%. This is below the industry average of 7.58%.
Industry RankSector Rank
ROA 2.26%
ROE 4.59%
ROIC 3.6%
ROA(3y)3.3%
ROA(5y)1.52%
ROE(3y)6.57%
ROE(5y)3.03%
ROIC(3y)4.55%
ROIC(5y)4.78%
TRS Yearly ROA, ROE, ROICTRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

TRS has a Profit Margin (3.36%) which is comparable to the rest of the industry.
TRS's Profit Margin has declined in the last couple of years.
TRS has a Operating Margin of 5.87%. This is in the lower half of the industry: TRS underperforms 68.18% of its industry peers.
TRS's Operating Margin has declined in the last couple of years.
The Gross Margin of TRS (21.74%) is comparable to the rest of the industry.
TRS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.87%
PM (TTM) 3.36%
GM 21.74%
OM growth 3Y-22.8%
OM growth 5Y-16.54%
PM growth 3Y-26.81%
PM growth 5Y-28.08%
GM growth 3Y-5.16%
GM growth 5Y-4.21%
TRS Yearly Profit, Operating, Gross MarginsTRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

6

2. Health

2.1 Basic Checks

TRS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
TRS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, TRS has less shares outstanding
TRS has a worse debt/assets ratio than last year.
TRS Yearly Shares OutstandingTRS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
TRS Yearly Total Debt VS Total AssetsTRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

TRS has an Altman-Z score of 2.13. This is not the best score and indicates that TRS is in the grey zone with still only limited risk for bankruptcy at the moment.
TRS has a Altman-Z score of 2.13. This is in the better half of the industry: TRS outperforms 68.18% of its industry peers.
TRS has a debt to FCF ratio of 16.75. This is a negative value and a sign of low solvency as TRS would need 16.75 years to pay back of all of its debts.
The Debt to FCF ratio of TRS (16.75) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.63 indicates that TRS is somewhat dependend on debt financing.
TRS has a better Debt to Equity ratio (0.63) than 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.75
Altman-Z 2.13
ROIC/WACC0.46
WACC7.77%
TRS Yearly LT Debt VS Equity VS FCFTRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

TRS has a Current Ratio of 2.82. This indicates that TRS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.82, TRS belongs to the best of the industry, outperforming 95.45% of the companies in the same industry.
TRS has a Quick Ratio of 1.49. This is a normal value and indicates that TRS is financially healthy and should not expect problems in meeting its short term obligations.
TRS has a better Quick ratio (1.49) than 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 2.82
Quick Ratio 1.49
TRS Yearly Current Assets VS Current LiabilitesTRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

The earnings per share for TRS have decreased by -3.31% in the last year.
Measured over the past years, TRS shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.59% on average per year.
TRS shows a small growth in Revenue. In the last year, the Revenue has grown by 3.80%.
TRS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.04% yearly.
EPS 1Y (TTM)-3.31%
EPS 3Y-9.51%
EPS 5Y-0.59%
EPS Q2Q%24.32%
Revenue 1Y (TTM)3.8%
Revenue growth 3Y2.57%
Revenue growth 5Y5.04%
Sales Q2Q%6.42%

3.2 Future

TRS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.37% yearly.
TRS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.51% yearly.
EPS Next Y11.07%
EPS Next 2Y14.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.52%
Revenue Next 2Y5.51%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
TRS Yearly Revenue VS EstimatesTRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
TRS Yearly EPS VS EstimatesTRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.21, TRS is valued on the expensive side.
63.64% of the companies in the same industry are more expensive than TRS, based on the Price/Earnings ratio.
TRS is valuated rather cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 13.87, which indicates a correct valuation of TRS.
TRS's Price/Forward Earnings ratio is in line with the industry average.
TRS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 17.21
Fwd PE 13.87
TRS Price Earnings VS Forward Price EarningsTRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

63.64% of the companies in the same industry are cheaper than TRS, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as TRS.
Industry RankSector Rank
P/FCF 47.06
EV/EBITDA 13.59
TRS Per share dataTRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
TRS's earnings are expected to grow with 14.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.55
PEG (5Y)N/A
EPS Next 2Y14.37%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.53%, TRS is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.88, TRS is paying slightly less dividend.
With a Dividend Yield of 0.53, TRS pays less dividend than the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 0.53%

5.2 History

TRS has been paying a dividend for over 5 years, so it has already some track record.
TRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
TRS Yearly Dividends per shareTRS Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

20.87% of the earnings are spent on dividend by TRS. This is a low number and sustainable payout ratio.
DP20.87%
EPS Next 2Y14.37%
EPS Next 3YN/A
TRS Yearly Income VS Free CF VS DividendTRS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
TRS Dividend Payout.TRS Dividend Payout, showing the Payout Ratio.TRS Dividend Payout.PayoutRetained Earnings

TRIMAS CORP

NASDAQ:TRS (7/11/2025, 8:00:02 PM)

After market: 30.11 0 (0%)

30.11

+0.04 (+0.13%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners103.2%
Inst Owner Change-0.08%
Ins Owners6.25%
Ins Owner Change5.03%
Market Cap1.22B
Analysts76.67
Price Target34.83 (15.68%)
Short Float %9.68%
Short Ratio6.57
Dividend
Industry RankSector Rank
Dividend Yield 0.53%
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP20.87%
Div Incr Years0
Div Non Decr Years3
Ex-Date05-06 2025-05-06 (0.04)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.63%
Min EPS beat(2)-10.46%
Max EPS beat(2)13.72%
EPS beat(4)1
Avg EPS beat(4)-9.06%
Min EPS beat(4)-20.05%
Max EPS beat(4)13.72%
EPS beat(8)3
Avg EPS beat(8)-7.05%
EPS beat(12)4
Avg EPS beat(12)-7.04%
EPS beat(16)7
Avg EPS beat(16)-4.68%
Revenue beat(2)1
Avg Revenue beat(2)0.72%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)1.64%
Revenue beat(4)1
Avg Revenue beat(4)-0.97%
Min Revenue beat(4)-5.11%
Max Revenue beat(4)1.64%
Revenue beat(8)2
Avg Revenue beat(8)-4.16%
Revenue beat(12)3
Avg Revenue beat(12)-4.14%
Revenue beat(16)3
Avg Revenue beat(16)-3.69%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.37%
EPS NY rev (1m)0%
EPS NY rev (3m)2.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.03%
Valuation
Industry RankSector Rank
PE 17.21
Fwd PE 13.87
P/S 1.3
P/FCF 47.06
P/OCF 15.97
P/B 1.78
P/tB 8.37
EV/EBITDA 13.59
EPS(TTM)1.75
EY5.81%
EPS(NY)2.17
Fwd EY7.21%
FCF(TTM)0.64
FCFY2.13%
OCF(TTM)1.89
OCFY6.26%
SpS23.11
BVpS16.89
TBVpS3.6
PEG (NY)1.55
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.26%
ROE 4.59%
ROCE 4.49%
ROIC 3.6%
ROICexc 3.7%
ROICexgc 6.75%
OM 5.87%
PM (TTM) 3.36%
GM 21.74%
FCFM 2.77%
ROA(3y)3.3%
ROA(5y)1.52%
ROE(3y)6.57%
ROE(5y)3.03%
ROIC(3y)4.55%
ROIC(5y)4.78%
ROICexc(3y)4.82%
ROICexc(5y)5.17%
ROICexgc(3y)9.3%
ROICexgc(5y)10.22%
ROCE(3y)5.66%
ROCE(5y)5.96%
ROICexcg growth 3Y-26.13%
ROICexcg growth 5Y-19.63%
ROICexc growth 3Y-23.76%
ROICexc growth 5Y-16.4%
OM growth 3Y-22.8%
OM growth 5Y-16.54%
PM growth 3Y-26.81%
PM growth 5Y-28.08%
GM growth 3Y-5.16%
GM growth 5Y-4.21%
F-Score7
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.75
Debt/EBITDA 3.64
Cap/Depr 78.45%
Cap/Sales 5.39%
Interest Coverage 2.9
Cash Conversion 64.03%
Profit Quality 82.49%
Current Ratio 2.82
Quick Ratio 1.49
Altman-Z 2.13
F-Score7
WACC7.77%
ROIC/WACC0.46
Cap/Depr(3y)86.35%
Cap/Depr(5y)84.94%
Cap/Sales(3y)5.59%
Cap/Sales(5y)5.46%
Profit Quality(3y)59.07%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.31%
EPS 3Y-9.51%
EPS 5Y-0.59%
EPS Q2Q%24.32%
EPS Next Y11.07%
EPS Next 2Y14.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.8%
Revenue growth 3Y2.57%
Revenue growth 5Y5.04%
Sales Q2Q%6.42%
Revenue Next Year5.52%
Revenue Next 2Y5.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.63%
EBIT growth 3Y-20.81%
EBIT growth 5Y-12.34%
EBIT Next Year42.4%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.1%
FCF growth 3Y-47.6%
FCF growth 5Y-22.52%
OCF growth 1Y0.08%
OCF growth 3Y-21.96%
OCF growth 5Y-3.34%